The excitement around Moderna's cancer vaccine is cooling. Here's why.
Moderna Inc MRNA
News
Moderna's cancer vaccine is 'likely' to get approved. Skeptics question if it will be the best option.
The stock market is splitting in two. Is that signaling trouble ahead, or just a new set of winners?
Moderna's cancer vaccine hits its targets, but a data leak rattled investors and the stock tumbled
Moderna has a plan to revolutionize how certain cancers are treated. We're about to find out its potential in melanoma.
7 healthcare stocks that stand out as investors pay up for the sector
7 healthcare stocks that stand out as -2-
Flu season is already here. Here's what to know about this year's flu shots.
Tempus Enters Multiyear Collaboration With Moderna, Merck Aimed at Commercializing Cancer Drug
Citi tells investors it's time to sell Moderna after 600%-plus stock gains
Moderna will reveal the data for its mRNA cancer vaccine next month. Here's why it matters.
23 best-performing stocks of August, as the software industry continues its recovery
23 best-performing stocks of August, as the -2-
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech, Novavax — Update
FDA Approves Seasonal Covid-19 Vaccines From Moderna, Pfizer, BioNTech
Moderna to Sell $2 Billion Convertible Notes in Private Placement
The Treasury, the Fed and the threat to your -2-
The Treasury, the Fed and the threat to your money
Moderna's personalized mRNA shot could reshape the fight against skin cancer - but it may also be overhyped
Moderna's cancer-vaccine breakthrough drives broad biopharma stock rally
United States